• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华法林剂量的计算机辅助--对治疗质量的影响。

Computerised assistance for warfarin dosage--effects on treatment quality.

机构信息

Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, SE-118 83 Stockholm, Sweden.

出版信息

Eur J Intern Med. 2012 Dec;23(8):742-4. doi: 10.1016/j.ejim.2012.07.011. Epub 2012 Aug 20.

DOI:10.1016/j.ejim.2012.07.011
PMID:22917757
Abstract

BACKGROUND

Well-managed warfarin treatment with a high time in therapeutic range (TTR) corresponds to fewer bleedings or thromboembolic complications. Many small centres manage their warfarin dosing manually, with little or no knowledge of their treatment quality as measured by TTR. AuriculA is a Swedish National web-based anticoagulation dosing system. Our hypothesis was that the web based dosing system, compared to manual dosing, would improve the TTR.

METHODS

Retrospective cohort study of medical records from patients with atrial fibrillation on warfarin treatment from two centres, with previously manual warfarin dosing regimens. Data for calculation of TTR was extracted manually from medical records from the time when using manual dosing and compared with the computerised regimen.

RESULTS

In centre 1, the mean TTR was significantly increased after the introduction of AuriculA, from 64.3% (95% CI 58.8-69.8) to 71.3% (95% CI 67.7-74.8), p=0.03. In centre 2, a high TTR of 73.6% (95% CI 71.3-75.9) was maintained after the implementation, 74.0% (95% CI 71.6-76.3). INR tests were prescribed significantly more frequent after the introduction of AuriculA in both centres; 20% more often at centre 1 and 21% at centre 2.

CONCLUSION

Computerised dosing assistance within the Swedish national quality registry AuriculA improves or maintains a high treatment quality with warfarin as measured by TTR.

摘要

背景

华法林治疗管理良好,治疗时间在治疗范围内(TTR)对应更少的出血或血栓栓塞并发症。许多小型中心手动管理其华法林剂量,几乎不了解或根本不了解 TTR 测量的治疗质量。AuriculA 是瑞典国家基于网络的抗凝药物剂量系统。我们的假设是,与手动剂量相比,基于网络的剂量系统将改善 TTR。

方法

这是一项来自两个中心的房颤患者服用华法林治疗的病历回顾性队列研究,此前使用的是手动华法林剂量方案。从使用手动剂量时的病历中手动提取 TTR 计算数据,并与计算机化方案进行比较。

结果

在中心 1,引入 AuriculA 后 TTR 显著增加,从 64.3%(95%CI 58.8-69.8)增加到 71.3%(95%CI 67.7-74.8),p=0.03。在中心 2,实施后维持了 73.6%(95%CI 71.3-75.9)的高 TTR,74.0%(95%CI 71.6-76.3)。在引入 AuriculA 后,两个中心的 INR 测试都明显更频繁地开处方;中心 1 增加 20%,中心 2 增加 21%。

结论

瑞典国家质量登记处 AuriculA 中的计算机化剂量辅助提高或维持了 TTR 测量的华法林治疗质量。

相似文献

1
Computerised assistance for warfarin dosage--effects on treatment quality.华法林剂量的计算机辅助--对治疗质量的影响。
Eur J Intern Med. 2012 Dec;23(8):742-4. doi: 10.1016/j.ejim.2012.07.011. Epub 2012 Aug 20.
2
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.瑞典的抗凝控制:来自国家质量登记处 AuriculA 的治疗范围内时间、大出血和血栓栓塞并发症的报告。
Eur Heart J. 2011 Sep;32(18):2282-9. doi: 10.1093/eurheartj/ehr134. Epub 2011 May 26.
3
Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses.计算机辅助华法林剂量调整在瑞典国家质量登记处 AuriculA 中的应用——算法建议比手动调整剂量更有效。
Thromb Res. 2013 Feb;131(2):130-4. doi: 10.1016/j.thromres.2012.11.016. Epub 2012 Dec 8.
4
Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy.随机比较一种简单的华法林剂量算法与计算机化的抗凝管理系统,以控制华法林维持治疗。
Thromb Haemost. 2012 Dec;108(6):1228-35. doi: 10.1160/TH12-06-0433. Epub 2012 Sep 26.
5
Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.心房颤动患者 INR 的变异性及其与死亡率、卒中、出血和住院的关系。
Thromb Res. 2012 Jan;129(1):32-5. doi: 10.1016/j.thromres.2011.07.004. Epub 2011 Aug 17.
6
Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.华法林剂量调整实践的差异是导致不同中心和国家抗凝控制质量差异的原因:RE-LY 试验中接受华法林治疗的患者分析。
Circulation. 2012 Nov 6;126(19):2309-16. doi: 10.1161/CIRCULATIONAHA.112.101808. Epub 2012 Oct 1.
7
A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.一项前瞻性研究,旨在通过积极的华法林剂量调整算法,使心脏瓣膜手术后 INR 达到并维持在 2 至 3 之间。
Thromb Haemost. 2011 Feb;105(2):232-8. doi: 10.1160/TH10-05-0324. Epub 2010 Dec 21.
8
Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.药师管理的住院患者抗凝治疗启动和滴定服务的疗效和安全性。
J Clin Pharm Ther. 2011 Oct;36(5):585-91. doi: 10.1111/j.1365-2710.2010.01216.x. Epub 2010 Nov 12.
9
Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing.心脏瓣膜手术后头三个月华法林敏感性降低:剂量调整的意义。
Thromb Res. 2010 Mar;125(3):224-9. doi: 10.1016/j.thromres.2009.02.012. Epub 2009 Mar 31.
10
Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis.机械心脏瓣膜置换术后患者华法林治疗质量与预后
Heart. 2017 Feb;103(3):198-203. doi: 10.1136/heartjnl-2016-309585. Epub 2016 Sep 2.

引用本文的文献

1
Patient compliance with an anticoagulation management system based on a smartphone application.基于智能手机应用的抗凝管理系统的患者依从性。
J Thromb Thrombolysis. 2019 Aug;48(2):263-269. doi: 10.1007/s11239-019-01859-0.
2
Triple therapy after PCI - Warfarin treatment quality and bleeding risk.PCI 后三联治疗 - 华法林治疗质量和出血风险。
PLoS One. 2018 Dec 18;13(12):e0209187. doi: 10.1371/journal.pone.0209187. eCollection 2018.
3
Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation.
利伐沙班用于德国心房颤动患者预防卒中的成本效益
Pharmacoeconomics. 2015 Mar;33(3):271-83. doi: 10.1007/s40273-014-0236-9.
4
Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.维生素 K 拮抗剂控制质量与心房颤动患者结局的关系:一项荟萃分析和荟萃回归。
Thromb J. 2014 Jun 24;12:14. doi: 10.1186/1477-9560-12-14. eCollection 2014.
5
Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review.心房颤动和静脉血栓栓塞研究中报告的维生素K拮抗剂控制措施:一项系统评价。
BMJ Open. 2014 Jun 20;4(6):e005379. doi: 10.1136/bmjopen-2014-005379.
6
Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data.芬兰心房颤动患者的华法林治疗:基于初级医疗保健数据的回顾性登记研究。
BMJ Open. 2014 Feb 27;4(2):e004071. doi: 10.1136/bmjopen-2013-004071.